Tokyo Smoke introduces four medical cannabis strains in collaboration with Aphria, one of Canada’s largest licensed producers of medical marijuana.
This is the first time a Canadian consumer brand will partner with a Licensed Producer to launch medical cannabis in Canada, an inaugural event for the lifestyle brand, as well as the Canadian marketplace.
Grown and distributed by Aphria under the ACMPR (Access to Cannabis for Medical Purposes Regulations), the cannabis strains will be available to patients with a valid medical prescription from August 24, 2017.
-
Related Story: Canada’s Tokyo Smoke Acquires U.S. Lifestyle Brand
The four strains will launch as a part of a kit ($250), featuring unique Tokyo Smoke packaging, five grams of each strain along with custom crafted black glass jars and special welcome accessories. They will be available to order through the Aphria website.
“This launch is the culmination of Tokyo Smoke’s vision of providing a beautiful cannabis experience in both design and product,” says Alan Gertner, co-founder and CEO of Tokyo Smoke. “When conceptualizing each strain, we wanted to pair consistent, high-quality cannabis with a focus on Tokyo Smoke branding, design and packaging. Contemporary customers deserve to have a cannabis experience that aligns with the rest of their lifestyle.”
